Join Anne, Mel, and Carla as they delve into the mysteries of endometrial hyperplasia. Meet Tiana, a 30-year-old grappling with irregular bleeding and an unexpected diagnosis post-polypectomy. Is it a benign polyp? Not quite—it's endometrial hyperplasia! But what does that mean?

In this episode, we uncover the nitty-gritty of endometrial hyperplasia, from its ominous precursor status to endometrial cancer to its surprising risk factors. Learn how unopposed estrogen, obesity, and even genetic conditions like Lynch Syndrome can tip the balance. Discover why menopausal hormone therapy and medications like tamoxifen might inadvertently set the stage for this condition.

Anne, Mel, and Carla break down the diagnostic journey, and cut through the old classification system's confusion and unveil the simplified guidelines of today.

But wait—what about treatment? From expectant management to the nuanced world of progesterone therapies and the pivotal role of the Mirena, they explore options tailored to each patient's needs. Should Tiana opt for fertility preservation? Discover the challenging decisions and implications when managing atypical hyperplasia, where the stakes are higher and fertility hangs in the balance.

Join us for this episode packed with clinical insights, debunking myths, and empowering women to navigate the complexities of endometrial health. Whether you're a clinician, patient, or simply curious, this podcast episode promises to demystify and enlighten. Tune in to The Uterine Sound for all things O&G!